期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 17, 期 10, 页码 1471-1477出版社
ELSEVIER SCI LTD
DOI: 10.1111/j.1469-0691.2011.03635.x
关键词
Access to care; access to drugs; drugs; leishmaniasis
According to disease burden estimates, leishmaniasis ranks third in disease burden in disability-adjusted life years caused by neglected tropical diseases and is the second cause of parasite-related deaths after malaria; but for a variety of reasons, it is not receiving the attention that would be justified seeing its importance. This is especially apparent in the unnecessarily and unacceptably poor access to timely and appropriate treatment for patients. To our knowledge, this is the first publication that addresses the major issues associated with poor access to drugs for leishmaniasis and that outlines a number of feasible and practical solutions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据